Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-10-25

Clinical Trial Update: Iray for Vascularized Pigment Epithelial Detachment (VPED) Secondary to Age Related Macular Degeneration [NA]

View source ↗

Summary

This entry reports a clinical trial update for the Iray device in vascularized pigment epithelial detachment associated with age-related macular degeneration, w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IRay

Snippet

Sponsor: Oraya Therapeutics, Inc. | Conditions: Retinal Pigment Epithelial Detachment With Vascularization, Age Related Macular Degeneration | NA | Status: UNKNOWN